Shandong Pharmaceutical Glass Co Ltd (600529) — Cash Flow Reinvestment Rate
Shandong Pharmaceutical Glass Co Ltd (600529) has a Cash Flow Reinvestment Rate of 5.03x as of December 2025, reinvesting CN¥208.74 Million (capex CN¥153.18 Million plus investments CN¥55.56 Million) from operating cash flow of CN¥41.46 Million. Explore capital reinvestment ratio of Shandong Pharmaceutical Glass Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Pharmaceutical Glass Co Ltd Cash Flow Reinvestment Rate (2001–2025)
Historical reinvestment intensity for Shandong Pharmaceutical Glass Co Ltd across 24 annual periods. Also explore Shandong Pharmaceutical Glass Co Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shandong Pharmaceutical Glass Co Ltd (2001–2025)
Year-by-year capital reinvestment analysis for Shandong Pharmaceutical Glass Co Ltd. For live market cap and broader valuation context, see Shandong Pharmaceutical Glass Co Ltd (600529) total market value.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | CN¥311.94 Million | CN¥576.92 Million | CN¥231.86 Million | ▼ -43.7% |
| 2024 | 0.96x | CN¥1.12 Billion | CN¥1.17 Billion | CN¥647.79 Million | ▼ -29.0% |
| 2023 | 1.35x | CN¥1.42 Billion | CN¥1.05 Billion | CN¥671.53 Million | ▼ -77.4% |
| 2022 | 5.97x | CN¥1.51 Billion | CN¥252.44 Million | CN¥710.71 Million | ▲ +407.1% |
| 2021 | 1.18x | CN¥883.26 Million | CN¥750.44 Million | CN¥809.26 Million | ▼ -12.9% |
| 2020 | 1.35x | CN¥765.20 Million | CN¥566.01 Million | CN¥535.20 Million | ▼ -11.9% |
| 2019 | 1.54x | CN¥919.69 Million | CN¥599.05 Million | CN¥591.69 Million | ▼ -1.7% |
| 2018 | 1.56x | CN¥727.38 Million | CN¥465.77 Million | CN¥347.38 Million | ▲ +32.0% |
| 2017 | 1.18x | CN¥487.24 Million | CN¥411.96 Million | CN¥167.06 Million | ▲ +102.9% |
| 2016 | 0.58x | CN¥295.25 Million | CN¥506.53 Million | CN¥196.58 Million | ▲ +22.7% |
| 2015 | 0.48x | CN¥185.12 Million | CN¥389.63 Million | CN¥155.12 Million | ▼ -5.1% |
| 2014 | 0.50x | CN¥133.53 Million | CN¥266.63 Million | CN¥133.53 Million | ▼ -10.6% |
| 2013 | 0.56x | CN¥150.49 Million | CN¥268.60 Million | CN¥150.49 Million | ▼ -86.9% |
| 2012 | 4.28x | CN¥122.10 Million | CN¥28.52 Million | CN¥122.10 Million | ▲ +440.5% |
| 2011 | 0.79x | CN¥217.53 Million | CN¥274.63 Million | CN¥217.53 Million | ▼ -14.2% |
| 2010 | 0.92x | CN¥200.37 Million | CN¥217.01 Million | CN¥200.37 Million | ▲ +94.3% |
| 2009 | 0.48x | CN¥118.44 Million | CN¥249.27 Million | CN¥118.44 Million | ▼ -72.5% |
| 2008 | 1.73x | CN¥158.40 Million | CN¥91.76 Million | CN¥158.40 Million | ▲ +31.6% |
| 2007 | 1.31x | CN¥160.82 Million | CN¥122.63 Million | CN¥160.82 Million | ▲ +45.8% |
| 2006 | 0.90x | CN¥70.59 Million | CN¥78.47 Million | CN¥70.59 Million | ▼ -53.4% |
| 2005 | 1.93x | CN¥85.09 Million | CN¥44.09 Million | CN¥85.09 Million | ▼ -57.8% |
| 2003 | 4.58x | CN¥271.74 Million | CN¥59.35 Million | CN¥271.74 Million | ▲ +344.7% |
| 2002 | 1.03x | CN¥112.49 Million | CN¥109.26 Million | CN¥112.49 Million | ▲ +16.3% |
| 2001 | 0.89x | CN¥25.32 Million | CN¥28.60 Million | CN¥25.32 Million | — |